All In Biotech

Drug Trial Radar · NCT06713837

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia. IMPACT-AML RPCT

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 339 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

339

Planned (sponsor's estimate)

Start

Feb 27, 2025

Primary completion

Jan 2028

Study completion Jan 2028

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Hospital Vall d'Hebron; Cyprus Institute of Neurology and Genetics; European Leukemia Net; Fundacion Para La Investigacion Hospital La Fe; Ostdeutsche Studiengruppe Haematologie Und Onkologie e.V.; Ospedale Pediatrico Bambin Gesù; Czech Lymphoma Study Group; Charite University, Berlin, Germany; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; University of Bologna; Hannover Medical School; German Society for Pediatric Oncology and Hematology GPOH gGmbH; Toscana Life Sciences Sviluppo s.r.l.; Lithuanian University of Health Sciences; Gruppo Italiano Malattie EMatologiche dell'Adulto; TIMELEX
First posted
Dec 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, open-label, pragmatic low intervention clinical trial comparing high intensity reinduction chemotherapy with low intensity therapies in 1st or 2nd relapse Acute Myeloid Leukemia. The study is funded by European Commission (HORIZON-MISS-2022-CANCER-01-03, Project ID 101104421)

Conditions

  • Acute Myeloid Leukemia
  • Relapse/Recurrence

Interventions

  • High intensity therapiesDrug

    * High and intermediate dose Cytarabine * Mitoxantrone - Etoposide - Cytarabine (MEC) * fludarabine - cytarabine - idarubicin - G-CSF (FLAG-IDA) * cladribine - high dose cytarabine (2CDA+HDAraC) * mitoxantrone - intermediate dose cytarabine (MiDAC) * fludarabine - amsacrine - cytarabine (FLAMSA) * Mitoxantrone - Intermediate-dose Cytarabine (HAM) * 3+7 (cytarabine and daunorubicine or idarubicine)

  • Low intensity therapiesDrug

    * Venetoclax+hypomethylating agent (decitabine, azacitidine) * Venetoclax+low dose cytarabine * Gilteritinib alone or in combination with low dose hypomethylating agent or low dose cytarabine * 2CDA 5mg/sqm + low dose cytarabine * Glasdegib+low dose cytarabine * Ivosidenib alone or in combination with low dose hypomethylating agent or low dose cytarabine * Single agent Gemtuzumab or Gemtuzumab in combination with alone or in combination with low dose hypomethylating agent or low dose cytarabine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To determine in R/R AML patients the clinical benefit of low intensity therapy as shown by event-free survival compared to high intensity therapy.Time frame: 36 months

Locations

51 sites in 8 countries. Site status is shown where the registry gives one.

  • University Hospital Brno

    Brno, Czechia · Recruiting

  • University Hospital Hradec Králové

    Hradec Králové, Czechia · Not yet recruiting

  • University Hospital Olomouc

    Olomouc, Czechia · Not yet recruiting

  • University Hospital in Ostrava

    Ostrava, Czechia · Not yet recruiting

  • University Hospital in Pilsen

    Pilsen, Czechia · Recruiting

  • Fakultní nemocnice Královské Vinohrady

    Prague, Czechia · Recruiting

  • Uniklinik RWTH Aachen

    Aachen, Germany · Recruiting

  • Universitätsmedizin Berlin Charité

    Berlin, Germany · Not yet recruiting

  • University Hospital Cologne

    Cologne, Germany · Not yet recruiting

  • University Hospital Greifswald

    Greifswald, Germany · Recruiting

  • Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH

    Halle, Germany · Recruiting

  • University Hospital Halle

    Halle, Germany · Recruiting

  • University Hospital of Rostock

    Rostock, Germany · Recruiting

  • Heinrich-Braun-Klinikum gGmbH

    Zwickau, Germany · Recruiting

  • Azienda Ospedaliero Universitaria Delle Marche

    Ancona, Italy · Recruiting

  • ASST degli Spedali Civili

    Brescia, Italy · Recruiting

  • ASST Valle Olonda

    Busto Arsizio, Italy · Recruiting

  • Istituto Oncologico Veneto IRCCS

    Castelfranco Veneto, Italy · Recruiting

  • AOU Careggi

    Florence, Italy · Recruiting

  • IRST Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

    Meldola, Italy · Recruiting

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Italy · Recruiting

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy · Not yet recruiting

  • Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli

    Naples, Italy · Not yet recruiting

  • Azienda Ospedale-Università Padova

    Padova, Italy · Recruiting

  • Fondazione IRCCS Policlinico San Matteo

    Pavia, Italy · Not yet recruiting

  • Azienda Unita Sanitaria Locale Di Piacenza

    Piacenza, Italy · Recruiting

  • Ospedale Infermi

    Rimini, Italy · Recruiting

  • Casa Sollievo Della Sofferenza

    San Giovanni Rotondo, Italy · Recruiting

  • Azienda Ospedaliero-Universitaria Senese

    Siena, Italy · Recruiting

  • Ospedale San Bortolo

    Vicenza, Italy · Recruiting

  • Policlinico Sant'Orsola

    Bologna, BO, Italy · Recruiting

  • IRCCS Ospedale Policlinico San Martino

    Genova, GE, Italy · Not yet recruiting

  • IRCCS Ospedale Policlinico San Martino

    Genova, GE, Italy · Recruiting

  • Ospedali Riuniti Villa Sofia - Cervello

    Palermo, PA, Italy · Recruiting

  • Ospedale S.Spirito - ASL Pescara

    Pescara, PE, Italy · Not yet recruiting

  • Ospedale Santa Maria della Misericordia

    Perugia, PG, Italy · Recruiting

  • Ospedale Santa Maria delle Croci

    Ravenna, RA, Italy · Recruiting

  • Policlinico Tor Vergata

    Roma, RM, Italy · Recruiting

  • Policlinico Umberto I

    Roma, RM, Italy · Recruiting

  • AOU Città della Salute e della Scienza di Torino

    Torino, TO, Italy · Recruiting

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.